Heart Failure
From the Journals
Spherical heart may predict cardiomyopathy, AFib
People with round hearts were more likely to develop cardiomyopathy and atrial fibrillation, according to a deep learning analysis of MRI images...
Guidelines
AHA, ACC push supervised exercise training for HFpEF
The statement aims to raise clinicians’ awareness of exercise as a therapy in preserved ejection fraction heart failure and convince Medicare that...
Conference Coverage
COAPT 5-year results ‘remarkable,’ but patient selection issues remain
MitraClip’s success persisted throughout long-term follow-up in the trial, which entered patients with severe MR secondary to heart failure.
Feature
Does new heart transplant method challenge definition of death?
Heart donation after circulatory rather than brain death increases donor hearts available to save lives, but the processes involved raise ethical...
Conference Coverage
Dapagliflozin’s HFpEF benefit tied to lower filling pressure
From the Journals
Mediterranean diet linked to 24% reduction in CVD risk in women
The researchers are calling for more sex-specific research to guide clinical practice.
News
Another FDA class I recall of Cardiosave Hybrid/Rescue IABPs
The coiled cable connecting the display and base on some units may fail, causing an unexpected shutdown, without warnings or alarms to alert the...
Conference Coverage
‘Unheard of’ PAH improvement with novel drug: STELLAR
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, had efficacy and safety in the first of three...
From the Journals
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
Conference Coverage
Wearable fluid sensor lowers risk of HF rehospitalizations: BMAD
By detecting elevated thoracic fluid levels, a wearable device improves management and outcomes of heart failure.
Conference Coverage
Fixed-dose combo pill for PAH promises accelerated benefit: A DUE
For pulmonary arterial hypertension, a fixed-dose combination of macitentan and tadalafil is safe and effective.